The new CEO of listed pan-Asian hospital giant IHH says it is looking to move into new markets like Indonesia and Vietnam. Meanwhile, it is also planning to expand its offering in India and Turkey, and turnaround its underperforming China assets.
Asia's largest for-profit healthcare group IHH Healthcare has made a buyout offer to Malaysian-based hospital group Ramsay Sime Darby Health Care (RSDHD) of US$1.35bn.
Australia's largest oncology provider Icon Group has been bought by EQT's infrastructure arm for AUS$2.4bn. Its CEO Mark Middleton tells HBI that the group now has its sights set on Europe.
Sovereign wealth funds are making some big entrances and exits in the Asia-Pacific with bids closing in QIC-owned oncology player Icon Group and Singapore's GIC acquiring a minority stake in Sunway hospital group Sunway Healthcare.
HBI understands that Malaysian/Indonesian hospital group Ramsay Sime Darby has appointed banks for a $300m IPO. One side of the JV says that expansion in healthcare is a key strategic focus, the other appears notably quiet about its investment in Asia. FY2020 saw profits drop for "the first time in many years" as COVID struck.
HBI State of the Regions continued on Tuesday morning with a look at SE Asia. It's "overloaded" in some parts with "substantial coverage gaps" in others, with big provider/payor conflict in most. Eduardo Banzon from the Asian Development Bank, Cole Sirucek from DocDoc, and Angus Slater from Bupa talk about the biggest challenges and opportunities on the continent.
Chinese private hospital operator Guodan Healthcare has refiled plans to IPO on the Hong Kong exchange and, if successful, will become the twelfth Chinese hospital in the country to list. But it's a crowded space and most of the 11 other stocks have underperformed in the last four years as our infographic shows.
Singapore-based 'doctor discovery platform' DocDoc has moved into China through a partnership with one of the world's largest insurance risk management companies, Kaitaiming (KTM), giving it access to 90% of the country's insurers. HBI speaks to CEO Cole Sirucek.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy